Paragraph: The DNA synthesizer market is estimated to be valued at US$ 4.30 Bn in 2023 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
DNA synthesizers are automated instruments used for organic synthesis of nucleic acids such as DNA and RNA in laboratories and research centers. They are widely used for applications such as gene editing, next-generation sequencing, molecular diagnostics, and forensics. With the advancements in biotechnological and pharmaceutical industries, there is an increasing demand for custom nucleic acid synthesis which requires DNA synthesizers.
Market Dynamics:
The growth of the DNA synthesizer market is attributed to the increasing demand for custom nucleic acid synthesis from biotech and pharma companies. Custom DNA synthesis allows researchers to design and produce strands of DNA with precise sequences for various applications in molecular biology and synthetic biology. This has led to an increased adoption of DNA synthesizers. Secondly, advancements in DNA synthesis technologies have improved efficiency and reduced cost, thereby further fueling the market growth. However, high installation and maintenance costs of DNA synthesizers could hamper the market to a certain extent.
SWOT Analysis (SWOT analysis is required for this section so heading is not changed)
Strength: DNA Synthesizer help researchers speed up research and enable new discoveries by automating DNA synthesis. They offer high accuracy and reproducibility for oligos and gene fragments in three or four weeks compared to traditional molecular cloning techniques that take months.
Weakness: The upfront cost of DNA synthesizers is quite high ranging from hundreds of thousands to over a million dollars limiting their adoption. There can also be reliability issues if not maintained properly.
Opportunity: Growing biosimilars and biologics development is creating demand for cost-effective DNA synthesis at scale. Advancements in microfluidics and new synthesis chemistries can help develop low-cost desktop DNA printers in the future.
Threats: Manual gene synthesis services provide a cheaper alternative though turnaround times are longer. Open source DIY bio movement can disrupt the market by providing plans for affordable homemade DNA synthesizers.
Key Takeaways
The global DNA Synthesizer Market Growth is expected to witness high growth, exhibiting CAGR of 20.% over the forecast period, due to increasing investments in genome editing and synthesis by biotech and pharmaceutical companies. Advancements are helping reduce the cost of gene assembly and scale up production volumes.
Regional analysis: North America currently dominates the global DNA Synthesizer market due to presence of major biotech players and availability of funding for genomic research from organizations like NIH. Asia Pacific is expected fastest growing market exhibiting over 25% CAGR driven by increasing biologics development in countries like China, India, and South Korea. Several local players are also entering this space to cater domestic demand.
Key players analysis: Key players operating in the DNA Synthesizer market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon Genetics, and LGC Biosearch Technologies. The market is consolidated with top five players accounting for over 60% share. Companies are focusing on scaling up synthesis volumes through innovative modular platforms.
Read More,
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian